tiprankstipranks
Trending News
More News >
Alcon Inc (ALC)
NYSE:ALC
US Market

Alcon (ALC) Earnings Dates, Call Summary & Reports

Compare
384 Followers

Earnings Data

Report Date
May 19, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.83
Last Year’s EPS
0.79
Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a predominantly positive underlying operational story: broad-based top-line growth across Surgical, Vision Care, and Ocular Health, successful new-product introductions (Unity, PanOptix Pro, Truqtra, Total30 expansions), strong free cash flow and accelerated shareholder returns, and explicit guidance for margin improvement and EPS growth in 2026. Offsetting these positives are notable near-term headwinds — tariff-related charges, margin compression in the quarter, an increasingly competitive IOL environment (with China and some international softness), and execution/phasing uncertainty as equipment and new-product ramps continue. On balance, the highlights (strong revenue growth, successful launches, robust cash generation, and disciplined capital allocation plus a clear plan to drive margins) outweigh the lowlights, though management is appropriately cautious on guidance and market visibility.
Company Guidance
Alcon’s 2026 guidance assumes aggregate eye‑care market growth of 3–4%, January exchange rates holding, and an average U.S. import tariff rate of ~15% (retaliatory tariffs unchanged); management expects 2026 sales growth of 5–7% (constant currency), with sales relatively level‑loaded and the second half more profitable than the first. They expect 2026 core gross margin to be broadly similar to 2025 (Q4 core gross margin was 62.5%), R&D of ~9% of sales, and have announced efficiency measures targeting $100M of annualized run‑rate savings (about $50M realized in 2026 at a one‑time cost of ~$150M) that should drive full‑year core operating‑margin expansion of ~70–170 basis points (Q4 core operating margin was 19%). On the bottom line they expect core diluted EPS growth of 9–12% (constant currency); 2025 free cash flow was $1.7B (114% of core net income), 2025 tariff‑related charges were $91M ($67M in cost of sales), interest expense in Q4 was $53M, and capital returns in 2025 totaled $848M (share repurchases $682M, dividends $166M) with the $750M repurchase program completed in January and a proposed dividend of $0.28/share.
Strong Overall Revenue Growth
Q4 sales of $2.7 billion, up 7% versus prior year; full-year momentum with management exiting 2025 on a stronger rate.
Surgical & Equipment Momentum (Unity)
Surgical revenue $1.5 billion, up 6% YoY; Equipment sales $77 million, up 18% driven by Unity VCS/CS launches and strong installation demand for Unity VCS (introduced mid‑2025).
Vision Care and Contact Lens Performance
Vision Care sales $1.2 billion, up 7% YoY; Contact Lens sales $683 million, up 4% (growth driven by product innovation and price), notable share gains in reusables and daily SiHy in Q4.
Ocular Health and Truqtra Launch Success
Ocular Health sales $474 million, up 12% YoY; Truqtra surpassed ~84,000 prescriptions and achieved ~3% U.S. market share within ~5 months of launch, with >33% commercial lives covered and high refill rates—management expects it to be a meaningful 2026 growth driver.
Product Pipeline and Notable Launches
Multiple high-impact launches and pipeline items: Unity VCS award recognition and broad roll-out; PanOptix Pro strong U.S. adoption (rolling out in Japan/Australia); TruPlus (FDA PMA) launching soon; Vivity upgrade planned for 2027; Total30 Multifocal for Astigmatism launched; Valeda showing encouraging adoption and reimbursement progress (6 of 7 MACs).
Strong Cash Generation & Shareholder Returns
Generated $1.7 billion free cash flow in 2025 (vs $1.6B in 2024); free cash flow was 114% of core net income; returned $848 million to shareholders in 2025 ($682M repurchases, $166M dividends) and completed $750M repurchase program ahead of schedule.
Prudent 2026 Guidance & Margin Improvement Plan
2026 outlook: sales growth guidance 5%–7%; market assumption 3%–4%; core diluted EPS growth guidance 9%–12%; core operating margin expected to expand ~70–170 bps driven by SG&A leverage, R&D at ~9% of sales, and announced efficiency program targeting $100M annualized savings (≈$50M recognized in 2026) at an estimated $150M cost.

Alcon (ALC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 19, 2026
2026 (Q1)
0.83 / -
0.793
Feb 24, 2026
2025 (Q4)
0.80 / 0.78
0.831-6.22% (-0.05)
Nov 11, 2025
2025 (Q3)
0.79 / 0.81
0.924-11.89% (-0.11)
Jul 30, 2025
2025 (Q2)
0.75 / 0.79
0.816-3.17% (-0.03)
May 13, 2025
2025 (Q1)
0.83 / 0.79
0.914-13.30% (-0.12)
Feb 26, 2025
2024 (Q4)
0.82 / 0.83
0.7964.38% (+0.03)
Nov 12, 2024
2024 (Q3)
0.83 / 0.92
0.75622.22% (+0.17)
Aug 20, 2024
2024 (Q2)
0.84 / 0.82
0.7844.13% (+0.03)
May 13, 2024
2024 (Q1)
0.84 / 0.91
0.80413.67% (+0.11)
Feb 27, 2024
2023 (Q4)
0.76 / 0.80
0.50956.35% (+0.29)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2026
$84.13
Nov 11, 2025
$77.36$79.44+2.69%
Jul 30, 2025
$89.18$87.55-1.83%
May 13, 2025
$92.92$87.24-6.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alcon Inc (ALC) report earnings?
Alcon Inc (ALC) is schdueled to report earning on May 19, 2026, After Close (Confirmed).
    What is Alcon Inc (ALC) earnings time?
    Alcon Inc (ALC) earnings time is at May 19, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ALC EPS forecast?
          ALC EPS forecast for the fiscal quarter 2026 (Q1) is 0.83.